BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 39574)

  • 1. Studies on the effects of MJ-9184-1 in man.
    Van Der Straeten M; Lamont H; Pauwels R
    Arzneimittelforschung; 1978; 28(7):1191-4. PubMed ID: 39574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A; Szalai Z; Pullerits T; Radeczky E
    Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction.
    Dyson AJ; Mackay AD
    Br J Dis Chest; 1980 Jan; 74(1):70-7. PubMed ID: 6101961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative dose-response curves for early evaluation of bronchodilator drugs.
    Larsson S; Svedmyr N
    Ann Allergy; 1978 Dec; 41(6):348-51. PubMed ID: 31829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchodilation and beta 2-selectivity of broxaterol in asthmatics: a crossover, single-blind, terbutaline- and placebo-controlled study.
    Petraglia A; Gurrieri G; Scarpitta M; Pisati R; Ansalone D
    Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):365-70. PubMed ID: 1359998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot clinical trial with a new beta 2-sympathomimetic bronchodilator, mabuterol.
    Ulmer WT; Scholz HJ; Baines A
    Arzneimittelforschung; 1984; 34(11A):1697-8. PubMed ID: 6152165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical testing of bronchospasmolytics in combined alternating test schedules].
    Kaik G
    Int J Clin Pharmacol Biopharm; 1976 Mar; 13(2):97-106. PubMed ID: 3472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nifedipine on salbutamol-induced bronchodilation in partially reversible airway obstruction.
    Rolla G; Arossa W; Bucca C; Bugiani M
    Int J Clin Pharmacol Res; 1986; 6(5):409-13. PubMed ID: 3781703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational fluid dynamics can detect changes in airway resistance in asthmatics after acute bronchodilation.
    De Backer JW; Vos WG; Devolder A; Verhulst SL; Germonpré P; Wuyts FL; Parizel PM; De Backer W
    J Biomech; 2008; 41(1):106-13. PubMed ID: 17698073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procaterol metered aerosol in patients with chronic obstructive pulmonary disease.
    Baronti A; Lelli M; Manini G; Verdiani P
    Int J Clin Pharmacol Res; 1987; 7(5):363-8. PubMed ID: 2889678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response study of a new oral bronchodilator, NAB 365 (clenbuterol).
    Brusasco V; Vibelli C; Chierichetti S; Ramoino R
    Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):589-93. PubMed ID: 365800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral NAB 365 (clenbuterol) and terbutaline in chronic obstructive lung disease: a double-blind, two-week study.
    Baronti A; Grieco A; Vibelli C
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):21-5. PubMed ID: 6988343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbuterol: a double-blind clinical trial comparing carbuterol and salbutamol.
    Cockcroft DW; Donevan RE; Copland GM
    Curr Ther Res Clin Exp; 1976 Feb; 19(2):170-9. PubMed ID: 813954
    [No Abstract]   [Full Text] [Related]  

  • 14. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
    Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S
    Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral therapy with beta-2-sympathomimetic drugs: comparative study of the bronchospasmolytic effect of tulobuterol and fenoterol in patients with reversible airway obstruction].
    Morr H; Nink M; Ferlinz R
    Pneumologie; 1990 Apr; 44(4):739-43. PubMed ID: 2192369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
    Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute bronchial and cardiovascular effects of oral pirbuterol and metaproterenol.
    Ence TJ; Tashkin DP; Ho D; Child JS
    Ann Allergy; 1979 Oct; 43(4):229-36. PubMed ID: 555600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute effect of inhaled beta(2)-agonists with different type of intrinsic activity on airway resistance in healthy volunteers].
    Kishimoto N; Ohnishi H; Fujita J; Kamei T; Tada S; Ueda N
    Arerugi; 2004 Apr; 53(4):417-22. PubMed ID: 15187486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the influence of the beta-sympatholytic drug KO 1366 (Bunitrolol on lung function (author's transl)].
    Kaik G
    Wien Klin Wochenschr; 1976 Jan; 88(2):68-71. PubMed ID: 3891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.